R21 Enhancing CAR T therapy in multiple myeloma
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
March 8, 2022
End Date
February 29, 2024
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
National Institutes of Health
Start Date
March 8, 2022
End Date
February 29, 2024